Listen
MENOTROPHINE LG (gonadotrophin), ovulation stimulant
GYNAECOLOGY - New medicinal product
Opinions on drugs -
Posted on
Jan 29 2016
Reason for request
Inclusion
No clinical benefit demonstrated when compared with MENOPUR in the induction of ovulation and in controlled ovarian hyperstimulation
- MENOTROPHINE LG has Marketing Authorisation in the induction of ovulation in the context of amenorrhoea or anovulation in women who have been unresponsive to treatment with clomiphene citrate and in controlled ovarian hyperstimulation to trigger the development of multiple follicles in the context of assisted reproductive technology treatments such as in-vitro fertilisation.
- There are no data supporting the clinical superiority of MENOTROPHINE LG over MENOPUR.
Clinical Benefit
| Substantial |
- |
Clinical Added Value
| no clinical added value |
- |
Therapeutic use
- |
English version
Contact Us
Évaluation des médicaments
